Smith (DS) PLC

M&A Activity • Nov 26, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5164I

Smith (DS) PLC

26 November 2018

26 November 2018

DS Smith- CNMV Authorisation

DS Smith is pleased to note that The Board of the Spanish Securities Market Commission (CNMV) has today authorised its proposed acquisition of Papeles y Cartones de Europa, S.A., known as Europac.

Following the authorisation, DS Smith anticipates the offer documentation being posted to shareholders of Europac as soon as practicable.

Miles Roberts, Group Chief Executive, said:

"I am delighted that we have authorisation from the CNMV. We look forward to completing the formal takeover process and integrating Europac into DS Smith to the benefit of all our stakeholders. This acquisition is a fantastic opportunity to enhance our customer coverage and offering in this important region."

DS Smith announced the proposed acquisition of Europac in June. It is a highly complementary, vertically integrated packaging business based in Spain with a diversified customer portfolio and strong customer relationships. In 2017 Europac delivered revenues of €868 million and had recurring EBITDA of €147 million. In the first nine months of this year, recurring EBITDA was €157 million and net profit was at €79 million, compared to €104 million and €58 million posted in the same period of 2017.

Enquiries

DS Smith Plc                                                       +44 (0)20 7756 1800

Investors

Hugo Fisher, Group Communications Director

Rachel Stevens, Investor Relations Director

Media

Greg Dawson, Group Corporate Affairs Director

Brunswick                                                           +44 (0)20 7404 5959

Simon Sporborg

Dan Roberts

Christina Clark

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCFKADQNBDDADB